These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30442679)
21. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression. Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528 [TBL] [Abstract][Full Text] [Related]
22. The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications. Krisht KM; Whitehead KJ; Niazi T; Couldwell WT Neurosurg Focus; 2010 Sep; 29(3):E2. PubMed ID: 20809760 [TBL] [Abstract][Full Text] [Related]
23. Cerebral cavernous malformation proteins at a glance. Draheim KM; Fisher OS; Boggon TJ; Calderwood DA J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819 [TBL] [Abstract][Full Text] [Related]
24. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations. Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800 [TBL] [Abstract][Full Text] [Related]
25. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Kleaveland B; Zheng X; Liu JJ; Blum Y; Tung JJ; Zou Z; Sweeney SM; Chen M; Guo L; Lu MM; Zhou D; Kitajewski J; Affolter M; Ginsberg MH; Kahn ML Nat Med; 2009 Feb; 15(2):169-76. PubMed ID: 19151727 [TBL] [Abstract][Full Text] [Related]
26. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways. Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819 [TBL] [Abstract][Full Text] [Related]
38. Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene. Garaci F; Marsili L; Riant F; Marziali S; Cécillon M; Pasquarelli R; Sangiuolo F; Floris R; Novelli G; Tournier-Lasserve E; Brancati F Neuroradiol J; 2015 Jun; 28(3):289-93. PubMed ID: 26246098 [TBL] [Abstract][Full Text] [Related]
39. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093 [TBL] [Abstract][Full Text] [Related]
40. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]